Mustang Bio Inc Cash Flow-to-Debt Ratio
Mustang Bio Inc cash flow-to-debt ratio. Mustang Bio Inc (MBIO) has a Cash Flow-to-Debt Ratio of -0.12x as of June 2026, meaning its operating cash flow of $-967.00K could theoretically repay 0% of its total liabilities ($8.07 Million) in one year. See Mustang Bio Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mustang Bio Inc (2015–2025)
Cash flow-to-debt ratio of Mustang Bio Inc from 2015 to 2025. Historical debt coverage capacity for Mustang Bio Inc across 11 annual periods. Also explore Mustang Bio Inc equity growth rate to track the company's year-over-year net asset growth rate.
Mustang Bio Inc Cash Flow-to-Debt Ratio by Year (2015–2025)
Mustang Bio Inc cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Mustang Bio Inc. For the full cash flow conversion analysis, see Mustang Bio Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.65x | $-5.26 Million | $8.06 Million | ▲ +24.6% |
| 2024 | -0.87x | $-11.41 Million | $13.18 Million | ▲ +69.2% |
| 2023 | -2.81x | $-49.48 Million | $17.62 Million | ▼ -99.2% |
| 2022 | -1.41x | $-65.07 Million | $46.15 Million | ▲ +66.5% |
| 2021 | -4.20x | $-53.67 Million | $12.77 Million | ▼ -29.1% |
| 2020 | -3.26x | $-37.32 Million | $11.46 Million | ▼ -111.2% |
| 2019 | -1.54x | $-33.58 Million | $21.79 Million | ▲ +49.1% |
| 2018 | -3.03x | $-19.24 Million | $6.36 Million | ▲ +14.4% |
| 2017 | -3.54x | $-12.95 Million | $3.66 Million | ▼ -176.1% |
| 2016 | -1.28x | $-4.13 Million | $3.22 Million | ▼ -236.7% |
| 2015 | -0.38x | $-1.57 Million | $4.13 Million | — |